Parkinson's Disease Clinical Trials in New York

Showing 41-60 of 177 trials

Drug Discovery for Parkinson's With Mutations in the GBA Gene

NCT05536388

The New York Stem Cell Foundation (NYSCF) Research Institute is performing this research to accelerate Parkinson's disease research and drug development by using cells from the body (such as skin or blood cells) to make stem cells and other types of cells, conduct research on the samples, perform genetic testing, and/or store the samples for future use. Through this research, researchers hope to identify future treatments or even cures for Parkinson's disease.

Parkinson DiseaseGaucher DiseaseHealthy+1 more

New York Stem Cell Foundation Research Institute60 participantsStarted Jul 2022

New York, New York, United States

COMPLETEDPhase 3< 1 mile

A Double-blind Study to Investigate Efficacy and Safety of Buntanetap Compared With Placebo in Participants With Early PD

NCT05357989

The purpose of this study is to measure safety and efficacy of buntanetap/posiphen capsules compared with placebo capsules in participants with early PD. Study details include: * The study duration will be up to 7-8 months. * The double-blind treatment duration will be up to 6 months. * There will be 5 in-clinic visits and 7 phone calls

Parkinson's Disease, Idiopathic

Annovis Bio Inc.523 participantsStarted Aug 2022

Birmingham, Alabama, United States • Sun City, Arizona, United States • Fountain Valley, California, United States +66 more locations

Drug Discovery for Parkinson's With Mutations in the GBA Gene

A Double-blind Study to Investigate Efficacy and Safety of Buntanetap Compared With Placebo in Participants With Early PD

Parkinson's Disease Trials in Other Cities

Pre-Active PD: Looking At Physical Activity Behavior Change in Parkinson's Disease

Evaluation of the Safety and Effectiveness of Bilateral Exablate Ablation of the Pallidothalamic Tract (PTT) for the Treatment of the Motor Complications of Parkinson's Disease (PD)

A Study in Subjects With Parkinson's Disease to Evaluate the Safety and Tolerability of Titration and Continuous Subcutaneous Infusion of ABBV-951 in an Outpatient Environment

Wearable Assessments in the Clinic and Home in PD

Clinical Evaluation of the Infinity Deep Brain Stimulation System

Consortium On Risk for Early-onset Parkinson's Disease (CORE PD)

Promoting Physical Activity Engagement for People With Early-mid Stage Parkinson's Disease (Engage-PD)

Effects Of Osteopathic Manipulative Medicine(OMM) On Lower Extremity Muscle Characteristics In Parkinson's Disease(PD) Patients

Effect of Osteopathic Manipulative Medicine on Parkinson Disease

Parkinson Disease and DBS: Cognitive Effects in GBA Mutation Carriers

An Extension of Istradefylline in Parkinson's Disease Patients Who Have Completed Studies 6002-EU-007, 6002-US-013 or 6002-US-018

A Pilot Biomarker Study Assessing Alpha-synuclein Aggregates Across Biofluid Reservoirs in Patients With Synucleinopathies

Open-Label Study With Pimavanserin on Activities of Daily Living in Subjects With Parkinson's Disease Psychosis

Early Longitudinal Imaging in Parkinson's Progression Markers Initiative Using [¹⁸F] AV-133 and DaTscan™

A Study to Assess Single and Multiple Doses of IkT-148009 in Healthy Elderly Participants and Parkinson's Patients

IPG Replacement Study (PREFERENCE-H)

Walking and mHealth to Increase Participation in Parkinson Disease

North American Prodromal Synucleinopathy Consortium

Other Conditions in New York